A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
19 Sep 2023
Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
5 Dec 2023
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
1 Oct 2023
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
8 Aug 2023
Removing race from the pooled cohort risk equations for cardiovascular disease (CVD) did not affect accuracy, according to results of a recent study, while another tested a prediction model based only on sex, age, and routine lab tests.
12 Dec 2023
The prevalence of obstructive sleep apnea is as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, or stroke, according to a new scientific statement from the American Heart Association (AHA).
29 Jun 2021
As a clinical diagnosis with several effective treatments, genitourinary syndrome of menopause falls within the internal medicine physician's broad domain.
1 Jul 2023
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
15 Dec 2020
While 80% of women have menopausal vasomotor symptoms, 70% of them go untreated.
1 Sep 2023
An editorial accompanying the study concluded that it is reasonable to recommend aspirin for the primary prevention of cardiovascular disease in select patients, including those who are at high risk for cardiovascular disease with low bleeding risk.
17 Sep 2019